Pepticker
§ Same category · GLP-1 / metabolic peptides

Retatrutide vs Tirzepatide

Side-by-side price comparison across every tracked vendor. Updated every 4–6 hours.

Pepticker may earn affiliate commissions (typically 5-20%) from linked vendors. See our Affiliate Disclosure.

Retatrutide
14
vendors tracked
from $2.83/mg
Tirzepatide
8
vendors tracked
from $2.08/mg
◎ Cheapest $/mg:Tirzepatide at $2.08/mg

Retatrutide

Triple GCG/GIP/GLP-1 agonist

Operational
$32.00
$3.20/mg
In stockOn sale
Buy with code →
Operational
$54.50
$5.45/mg
In stock70.3% vs best
Visit →
Operational
$59.99
$6.00/mg
In stockOn sale87.5% vs best
Visit →
Operational
$64.99
$6.50/mg
In stockOn sale103.1% vs best
Visit →
Operational
$78.00
$7.80/mg
In stock143.7% vs best
Visit →
Operational
$99.00
$9.90/mg
In stock209.4% vs best
Visit →
Operational
$107.25
$10.72/mg
In stock235.2% vs best
Visit →
Operational
$109.00
$10.90/mg
In stock240.6% vs best
Visit →
$109.00
$10.90/mg
In stock240.6% vs best
Visit →
$129.99
$13.00/mg
In stock306.2% vs best
Visit →
$134.99
$13.50/mg
In stockOn sale321.8% vs best
Visit →
Operational
$199.97
$20.00/mg
In stock524.9% vs best
Visit →
Sort:
2026-08-03

Tirzepatide

Dual GLP-1/GIP agonist

Operational
$24.00
$2.40/mg
In stock◎ Best $/mg
Buy with code →
Operational
$39.99
$4.00/mg
In stock66.6% vs best
Visit →
Operational
$58.49
$5.85/mg
In stockOn sale143.7% vs best
Visit →
Operational
$99.00
$9.90/mg
In stock312.5% vs best
Visit →
$99.99
$10.00/mg
In stock316.6% vs best
Visit →
Operational
$199.99
$20.00/mg
In stock733.3% vs best
Visit →
Sort:
2026-08-03

About Retatrutide

An investigational triple-agonist targeting GLP-1, GIP, and glucagon receptors. Phase 3 clinical trials for obesity are ongoing; research-compound version is sold via research-chemical vendors.

About Tirzepatide

A once-weekly dual GIP and GLP-1 receptor agonist studied for type-2 diabetes and obesity. Approved clinically in many jurisdictions; research-compound form is widely distributed.